All patients included were diagnosed with stage I to stage III hormone receptor–positive, human epidermal growth factor receptor-2 (ERBB2; formerly HER2)–negative invasive breast cancer and underwent AHT without chemotherapy. The gene discussed is ERBB2; the disease is invasive breast carcinoma.